Research to date has suggested that various alterations, including the production and accumulation of amyloid-beta (Aβ) and phosphorylated tau proteins, as well as mitochondrial and synaptic damage, inflammatory responses, oxidative stress, hormonal imbalance, and neuronal loss, are involved in the AD progression[6–14]. Here, MAPT is linked to Alzheimer disease.